Axsome Therapeutics (AXSM) Earnings
|
Expand Research on AXSM
| Next EPS Date | 8/10/26 | EPS Growth Rate | +14.4% |
|---|---|---|---|
| Average EPS % Beat Rate | -7.9% | Revenue Growth Rate | +48.1% |
| Average % Move 1-Wk after EPS | +1.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/26  |
Q226 | N/A | -$0.83 | N/A | N/A | $222.25M | N/A | N/A | N/A | ||
| 5/4/26 | Q126 | -$1.26 | -$0.83 | -$0.43 | $191.2M | $193.46M | N/A |  | | Details | |
| 2/23/26 |
Q425 | -$0.56 | -$0.73 | +$0.17 | $195.99M | $189.81M | N/A | | | Details | |
| 11/3/25 |
Q325 | -$0.95 | -$0.85 | -$0.10 | $171M | $162.45M | N/A | | | Details | |
| 8/4/25 |
Q225 | -$0.97 | -$1.06 | +$0.09 | $150.04M | $139.31M | N/A | | | Details | |
| 5/5/25 | Q125 | -$1.22 | -$1.30 | +$0.08 | $121.46M | $121.58M | N/A | | | Details | |
| 2/18/25 | Q424 | -$1.54 | -$0.96 | -$0.58 | $117.32M | $117.69M | N/A | | | Details | |
| 11/12/24 |
Q324 | N/A | -$1.38 | N/A | N/A | $98.32M | N/A | N/A | N/A |
